Viewing Study NCT05047094

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:34 AM
Ignite Modification Date: 2026-03-06 @ 7:48 AM
Study NCT ID: NCT05047094
Status: RECRUITING
Last Update Posted: 2025-12-02
First Post: 2021-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Safety and Efficacy Study for Combinational Treatment of DaRT and Check Point Inhibitor for Recurrent Unresectable or mHNSCC
Sponsor: Alpha Tau Medical LTD.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
None Skin Cancer View
None Metastatic Head-and-neck Squamous-cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Squamous Cell Carcinoma View
None SCC View
None Skin Cancer View
None Skin metastasis View
None HNSCC View
None Carcinoma, Squamous View
None Recurrent disease View
None Alpha radiation View
None Brachytherapy View
None Pembrolizumab View
None Check Point Inhibitor View
None KEYTRUDA View
None Immunomodulators View